Meridian Wealth Partners, LLC Gilead Sciences, Inc. Transaction History

Meridian Wealth Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $28,700 - $30,964	424 New	424 $30,000
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $31,354 - $34,258	-494 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $29,640 - $33,819	494 New	494 $32,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $20,927 - $26,312	-337 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $1,302 - $1,512	18 Added 5.64%	337 $26,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $19,978 - $25,590	319 New	319 $24,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Meridian Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Meridian Wealth Partners, LLC with notifications on news.